FINV vs. ASND

In the year-to-date period, FINV achieves a 27.77% return, which is significantly higher than ASND's 18.28% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for FinVolution Group (FINV) and Ascendis Pharma A/S (ASND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FINV Sharpe Ratio is 1.98, which is higher than the ASND Sharpe Ratio of 0.41. The chart below compares the historical Sharpe Ratios of FINV and ASND, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FINV's dividend yield for the trailing twelve months is around 3.31%, while ASND has not paid dividends to shareholders.

The maximum FINV drawdown since its inception was -89.64%, which is greater than ASND's maximum drawdown of -61.72%. Use the drawdown chart below to compare losses from any high point for FINV and ASND.

FinVolution Group (FINV) and Ascendis Pharma A/S (ASND) have volatilities of 11.22% and 11.37%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between FinVolution Group and Ascendis Pharma A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.